Subsequent Events	3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Event The Company's common stock is listed on The Nasdaq Global Market, or Nasdaq. One of Nasdaq’s listing requirements is that the Company's shares maintain a minimum bid price of at least $1.00. The Company received a deficiency notice from Nasdaq on April 26, 2023, advising that the closing bid price of its stock for the previous 30 consecutive business days was below the $1.00 minimum bid price requirement and, therefore, no longer satisfied this Nasdaq requirement. In accordance with Nasdaq rules, the Company has until October 23, 2023 (180 calendar days from the date of the Nasdaq deficiency notice) to regain compliance with the minimum bid price requirement. If at any time during the 180-day period, the bid price of the Company's common stock closes at or above $1.00 per share for a minimum of 10 consecutive business days, the Company expects that Nasdaq would provide a written confirmation of compliance and the matter will be closed. Alternatively, if the Company fails to regain compliance with the minimum bid price requirement prior to the expiration of the initial period, it may be eligible for an additional 180 calendar day compliance period, provided that it transfers its listing of its common stock to the Nasdaq Capital Market and meets certain other conditions. In the event that the Company does not regain compliance with the minimum bid price requirement prior to the expiration of the initial period, and if it appears to Nasdaq that it will not be able to cure the deficiency, or if the Company is not otherwise eligible to transfer its common stock to the Nasdaq Capital Market, the Company expects Nasdaq will provide it with written notification that its securities are subject to delisting from The Nasdaq Global Market. At that time, the Company may appeal the delisting determination to a hearings panel.

Subsequent Events

3 Months Ended

Mar. 31, 2023

14. Subsequent Event

The Company's common stock is listed on The Nasdaq Global Market, or Nasdaq. One of Nasdaq’s listing requirements is that the Company's shares maintain a minimum bid price of at least $1.00. The Company received a deficiency notice from Nasdaq on April 26, 2023, advising that the closing bid price of its stock for the previous 30 consecutive business days was below the $1.00 minimum bid price requirement and, therefore, no longer satisfied this Nasdaq requirement.

In accordance with Nasdaq rules, the Company has until October 23, 2023 (180 calendar days from the date of the Nasdaq deficiency notice) to regain compliance with the minimum bid price requirement. If at any time during the 180-day period, the bid price of the Company's common stock closes at or above $1.00 per share for a minimum of 10 consecutive business days, the Company expects that Nasdaq would provide a written confirmation of compliance and the matter will be closed. Alternatively, if the Company fails to regain compliance with the minimum bid price requirement prior to the expiration of the initial period, it may be eligible for an additional 180 calendar day compliance period, provided that it transfers its listing of its common stock to the Nasdaq Capital Market and meets certain other conditions. In the event that the Company does not regain compliance with the minimum bid price requirement prior to the expiration of the initial period, and if it appears to Nasdaq that it will not be able to cure the deficiency, or if the Company is not otherwise eligible to transfer its common stock to the Nasdaq Capital Market, the Company expects Nasdaq will provide it with written notification that its securities are subject to delisting from The Nasdaq Global Market. At that time, the Company may appeal the delisting determination to a hearings panel.